• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于热力学的聚乳酸/聚乳酸-羟基乙酸共聚物凝聚法药物微囊化。2. 决定微球形成的参数。

Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.

作者信息

Thomasin C, Merkle H P, Gander B

机构信息

Department of Pharmacy, ETH, Zurich, Switzerland.

出版信息

J Pharm Sci. 1998 Mar;87(3):269-75. doi: 10.1021/js970048j.

DOI:10.1021/js970048j
PMID:9523977
Abstract

Phase separation (frequently called coacervation) of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) is a classical method for drug microencapsulation. Here, attempts have been made to describe this process in the light of thermodynamics. Different PLA/PLGAs were dissolved in either dichloromethane or ethyl acetate, phase separated by addition of the coacervating agent silicone oil (PDMS), and hardened in either octamethylcyclotetrasiloxane or hexane. Various stages of phase separation were defined microscopically, and the coacervate and continuous phases characterized with respect to volume, composition, polymer molecular weight, and rheological behavior. The optimal amount of PDMS was inversely proportional to the polymer molecular weight and hydrophilicity, and a coacervate viscosity of above 5-10 Pa s was required for stable coacervate droplets. The composition and, consequently, viscosity of the coacervate and continuous phases depended on the polymer-solvent-PDMS interactions, as analyzed by the parameters chi (Flory), delta (Hildebrand), and delta(int)E (Hô). In general, the lattice model of FIory and Scott describing polymer-polymer incompatibility best explained the results. The interaction parameters and viscosity of the phases were also helpful to explain microsphere characteristics such as residual solvent and particle size. The data suggest that microsphere formation by polyester coacervation is primarily driven by molecular interactions between polymer, solvents, and coacervating agent.

摘要

聚乳酸(PLA)和聚乳酸 - 乙醇酸共聚物(PLGA)的相分离(通常称为凝聚)是药物微囊化的经典方法。在此,已尝试从热力学角度描述这一过程。将不同的PLA/PLGA溶解于二氯甲烷或乙酸乙酯中,通过添加凝聚剂硅油(PDMS)进行相分离,并在八甲基环四硅氧烷或己烷中硬化。通过显微镜确定相分离的各个阶段,并对凝聚相和连续相的体积、组成、聚合物分子量和流变行为进行表征。PDMS的最佳用量与聚合物分子量和亲水性成反比,稳定的凝聚液滴需要凝聚相粘度高于5 - 10 Pa·s。凝聚相和连续相的组成以及因此的粘度取决于聚合物 - 溶剂 - PDMS相互作用,通过参数χ(弗洛里)、δ(希尔德布兰德)和δ(int)E(霍)进行分析。一般来说,描述聚合物 - 聚合物不相容性的弗洛里和斯科特晶格模型最能解释结果。相的相互作用参数和粘度也有助于解释微球特性,如残留溶剂和粒径。数据表明,聚酯凝聚法形成微球主要是由聚合物、溶剂和凝聚剂之间分子相互作用驱动的。

相似文献

1
Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.基于热力学的聚乳酸/聚乳酸-羟基乙酸共聚物凝聚法药物微囊化。2. 决定微球形成的参数。
J Pharm Sci. 1998 Mar;87(3):269-75. doi: 10.1021/js970048j.
2
Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations.
J Pharm Sci. 1998 Mar;87(3):259-68. doi: 10.1021/js970047r.
3
Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.用于将肽和蛋白质微囊化到可生物降解聚酯中的超声雾化及随后的聚合物去溶剂化。
J Microencapsul. 2003 Sep-Oct;20(5):553-67. doi: 10.1080/0265204031000148059.
4
Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.使用微流控芯片合成均匀的聚(d,l-丙交酯)和聚(d,l-丙交酯-共-乙交酯)微球以作比较。
Electrophoresis. 2014 Feb;35(2-3):316-22. doi: 10.1002/elps.201300185. Epub 2013 Sep 19.
5
Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.预测聚合物基质中药物释放的简单测量方法——溶解度参数和特性粘度。
Eur J Pharm Biopharm. 2015 May;92:1-7. doi: 10.1016/j.ejpb.2015.02.001. Epub 2015 Feb 7.
6
Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.含雌二醇的聚(D,L-乳酸)(PLA)或D,L-丙交酯/乙交酯共聚物(PLGA)微球的制备与评价
Pharmazie. 2002 Oct;57(10):695-7.
7
Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.水相药物的 o/o/o 溶剂萃取微囊化包封。
Int J Pharm. 2011 May 16;409(1-2):89-95. doi: 10.1016/j.ijpharm.2011.02.029. Epub 2011 Feb 26.
8
Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.喷雾干燥法制备聚乳酸及聚乳酸-乙醇酸共聚物微球的评估
J Microencapsul. 1993 Oct-Dec;10(4):487-97. doi: 10.3109/02652049309015325.
9
Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.单一或混合聚合物类型对包裹在聚乳酸/聚乳酸-羟基乙酸共聚物微球中的生长抑素类似物的体外控释及血浆水平的重要性。
J Control Release. 2004 May 18;96(3):437-48. doi: 10.1016/j.jconrel.2004.02.015.
10
Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.鉴于治疗布鲁氏菌感染,将庆大霉素包裹于聚乳酸/聚乳酸-羟基乙酸共聚物微球中。
Int J Pharm. 2000 Feb 25;196(1):115-25. doi: 10.1016/s0378-5173(99)00448-2.

引用本文的文献

1
Vortioxetine: A Potential Drug for Repurposing for Glioblastoma Treatment via a Microsphere Local Delivery System.伏硫西汀:一种有望通过微球局部给药系统重新用于治疗胶质母细胞瘤的药物。
ACS Biomater Sci Eng. 2025 Apr 14;11(4):2203-2215. doi: 10.1021/acsbiomaterials.5c00068. Epub 2025 Apr 1.
2
Novel Development of Nanoparticles-A Promising Direction for Precise Tumor Management.纳米颗粒的新进展——精确肿瘤管理的一个有前景的方向。
Pharmaceutics. 2022 Dec 21;15(1):24. doi: 10.3390/pharmaceutics15010024.
3
PLA micro- and nano-particles.聚乳酸微颗粒和纳米颗粒。
Adv Drug Deliv Rev. 2016 Dec 15;107:176-191. doi: 10.1016/j.addr.2016.05.020. Epub 2016 Jun 1.
4
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.聚乳酸-乙醇酸共聚物(PLGA)作为可生物降解的控释药物载体。
Polymers (Basel). 2011 Sep 1;3(3):1377-1397. doi: 10.3390/polym3031377. Epub 2011 Aug 26.